1. Home
  2. LCTX vs EXFY Comparison

LCTX vs EXFY Comparison

Compare LCTX & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCTX
  • EXFY
  • Stock Information
  • Founded
  • LCTX 1990
  • EXFY 2008
  • Country
  • LCTX United States
  • EXFY United States
  • Employees
  • LCTX N/A
  • EXFY N/A
  • Industry
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • LCTX Health Care
  • EXFY Technology
  • Exchange
  • LCTX Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • LCTX 110.2M
  • EXFY 343.4M
  • IPO Year
  • LCTX N/A
  • EXFY 2021
  • Fundamental
  • Price
  • LCTX $0.55
  • EXFY $3.18
  • Analyst Decision
  • LCTX Strong Buy
  • EXFY Buy
  • Analyst Count
  • LCTX 5
  • EXFY 4
  • Target Price
  • LCTX $4.80
  • EXFY $3.50
  • AVG Volume (30 Days)
  • LCTX 2.9M
  • EXFY 426.4K
  • Earning Date
  • LCTX 03-06-2025
  • EXFY 02-20-2025
  • Dividend Yield
  • LCTX N/A
  • EXFY N/A
  • EPS Growth
  • LCTX N/A
  • EXFY N/A
  • EPS
  • LCTX N/A
  • EXFY N/A
  • Revenue
  • LCTX $8,719,000.00
  • EXFY $137,440,000.00
  • Revenue This Year
  • LCTX N/A
  • EXFY N/A
  • Revenue Next Year
  • LCTX $41.15
  • EXFY $6.09
  • P/E Ratio
  • LCTX N/A
  • EXFY N/A
  • Revenue Growth
  • LCTX N/A
  • EXFY N/A
  • 52 Week Low
  • LCTX $0.48
  • EXFY $1.24
  • 52 Week High
  • LCTX $1.61
  • EXFY $4.13
  • Technical
  • Relative Strength Index (RSI)
  • LCTX 47.26
  • EXFY 41.35
  • Support Level
  • LCTX $0.51
  • EXFY $3.07
  • Resistance Level
  • LCTX $0.60
  • EXFY $3.68
  • Average True Range (ATR)
  • LCTX 0.04
  • EXFY 0.17
  • MACD
  • LCTX 0.01
  • EXFY -0.08
  • Stochastic Oscillator
  • LCTX 53.85
  • EXFY 18.03

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.

Share on Social Networks: